Target Price | €31.65 |
Price | €24.75 |
Potential | 27.89% |
Number of Estimates | 17 |
17 Analysts have issued a price target Bayer 2025 . The average Bayer target price is €31.65. This is 27.89% higher than the current stock price. The highest price target is €38.00 53.57% , the lowest is €26.00 5.07% . | |
A rating was issued by 19 analysts: 4 Analysts recommend Bayer to buy, 15 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2025 of 27.89% . Most analysts recommend the Bayer stock at Hold. |
16 Analysts have issued a sales forecast Bayer 2024 . The average Bayer sales estimate is €46.9b . This is 0.46% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €48.1b 2.12% , the lowest is €46.1b 2.08% .
This results in the following potential growth metrics:
2023 | €47.6b | 6.11% |
---|---|---|
2024 | €46.9b | 1.55% |
2025 | €47.7b | 1.77% |
2026 | €48.5b | 1.61% |
2027 | €49.2b | 1.45% |
2028 | €50.1b | 1.88% |
16 Analysts have issued an Bayer EBITDA forecast 2024. The average Bayer EBITDA estimate is €10.4b . This is 11.75% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €10.9b 7.39% , the lowest is €10.0b 15.00% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €12.3b | 1.26% |
---|---|---|
2024 | €10.4b | 15.99% |
2025 | €10.8b | 3.69% |
2026 | €11.0b | 2.18% |
2027 | €11.0b | 0.40% |
2028 | €11.8b | 7.14% |
2023 | 25.91% | 7.86% |
---|---|---|
2024 | 22.11% | 14.66% |
2025 | 22.53% | 1.90% |
2026 | 22.65% | 0.53% |
2027 | 22.42% | 1.02% |
2028 | 23.58% | 5.17% |
11 Bayer Analysts have issued a net profit forecast 2024. The average Bayer net profit estimate is €2.2b . This is 275.72% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €4.3b 437.21% , the lowest is €1.1b 189.15% .
This results in the following potential growth metrics and future Net Margins:
2023 | €-2.9b | 170.85% |
---|---|---|
2024 | €2.2b | 175.81% |
2025 | €3.1b | 40.10% |
2026 | €3.4b | 9.36% |
2027 | €3.7b | 9.19% |
2028 | €4.2b | 12.57% |
2023 | -6.17% | 175.47% |
---|---|---|
2024 | 4.75% | 177.03% |
2025 | 6.54% | 37.68% |
2026 | 7.04% | 7.65% |
2027 | 7.57% | 7.53% |
2028 | 8.37% | 10.57% |
11 Analysts have issued a Bayer forecast for earnings per share. The average Bayer <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €2.27 . This is 275.97% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €4.35 437.21% , the lowest is €1.15 189.15% .
This results in the following potential growth metrics and future valuations:
2023 | €-2.99 | 170.85% |
---|---|---|
2024 | €2.27 | 175.92% |
2025 | €3.18 | 40.09% |
2026 | €3.47 | 9.12% |
2027 | €3.79 | 9.22% |
2028 | €4.27 | 12.66% |
Current | -19.48 | 170.89% |
---|---|---|
2024 | 11.07 | 156.83% |
2025 | 7.90 | 28.64% |
2026 | 7.23 | 8.48% |
2027 | 6.62 | 8.44% |
2028 | 5.88 | 11.18% |
Based on analysts' sales estimates for 2024, the Bayer stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 1.44 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 0.53 .
This results in the following potential growth metrics and future valuations:
Current | 1.43 | 14.88% |
---|---|---|
2024 | 1.44 | 0.66% |
2025 | 1.41 | 1.74% |
2026 | 1.39 | 1.58% |
2027 | 1.37 | 1.43% |
2028 | 1.35 | 1.84% |
Current | 0.52 | 35.94% |
---|---|---|
2024 | 0.53 | 0.46% |
2025 | 0.52 | 1.73% |
2026 | 0.51 | 1.59% |
2027 | 0.50 | 1.44% |
2028 | 0.49 | 1.84% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.